Today: 20 May 2026
UK stocks today: FTSE 100 retreats from record highs as BP, Shell slide on Venezuela oil deal
7 January 2026
2 mins read

UK stocks today: FTSE 100 retreats from record highs as BP, Shell slide on Venezuela oil deal

London, Jan 7, 2026, 10:57 GMT — Regular session

  • FTSE 100 down 0.5% mid-morning, led lower by energy and precious-metal miners
  • BP and Shell slide as oil prices fall on fresh U.S.-Venezuela supply headlines
  • Investors rotate into defensive utilities and property shares after Tuesday’s record close

Britain’s FTSE 100 edged lower on Wednesday, with energy and precious-metal miners dragging after a run of record highs, while utilities and real estate stocks drew defensive bids. The blue-chip index was down 0.5% by 1010 GMT; BP fell 2.9% and Shell slid 2.2%, while Topps Tiles rose 1.5% after reporting a 3.7% rise in first-quarter revenue. “Small caps are clearly more attractively valued than large caps in the UK,” Joachim Klement, head of investment strategy at Panmure Liberum, wrote in a note. Reuters

The move comes a day after London shares logged another record close, lifted by healthcare heavyweights and retailer updates. The FTSE 100 jumped 1.4% on Tuesday, with AstraZeneca up 5% after announcing a strategic collaboration with Bostongene, while Next climbed 4.9% after raising its annual profit outlook again and Ocado surged 11.6% on a strong Christmas-quarter read from market researcher Worldpanel by Numerator.

A shift in the Venezuela narrative has also hit the UK benchmark’s commodity-sensitive core. Reuters reported the Trump administration said it had reached a deal for the United States to import up to $2 billion of Venezuelan crude and take delivery of up to 50 million barrels, a move that pushed oil prices down on expectations of higher supply; Venezuela has not confirmed the deal.

Domestically, investors are also weighing fresh signs of strain in the real economy. A construction Purchasing Managers’ Index (PMI) survey — where 50 separates growth from contraction — showed activity contracted for a 12th straight month in December, with the headline reading at 40.1; the housebuilding sub-index fell to 33.5. “UK construction companies once again reported challenging business conditions and falling workloads,” S&P Global Market Intelligence economics director Tim Moore said. Reuters

Price pressure remains the other side of the rate-cut debate. A separate PMI report showed the final UK services reading for December was revised down to 51.4 from a preliminary 52.1, while input costs and prices charged rose; the report also flagged a 4.1% rise in the minimum wage in April to £12.71 an hour. The Bank of England cut rates last month to 3.75%, and investors are pricing one or two quarter-point cuts in 2026.

Across Europe, a broader rally also paused after a run of record closes, with traders cautious on geopolitics and awaiting U.S. macro data. “Investors have generally looked past geopolitics in recent years and have been rewarded for doing so,” Richard Flax, chief investment officer at wealth manager Moneyfarm, said, as traders looked ahead to the U.S. JOLTS job openings report due later on Wednesday. Reuters

But the FTSE’s early-year momentum leaves it exposed to sharp swings in oil, gold and headline risk, especially with energy and miners still among the index’s heaviest weights. Weak domestic demand indicators also raise the risk that any shift in rate expectations hits UK-facing shares harder than the exporters that dominate the blue-chip gauge.

Stock Market Today

  • Stocks Added to Zacks Strong Sell List on May 20th: BRCC, CVE, MITT
    May 20, 2026, 5:27 AM EDT. Three stocks joined the Zacks Rank #5 (Strong Sell) list on May 20th. BRC Inc. (BRCC), a coffee and apparel seller, saw its current year earnings estimate cut by 33.3%. Cenovus Energy Inc. (CVE), an oil and gas producer, had its earnings forecast lowered by 24.5%. AG Mortgage Investment Trust (MITT), a residential mortgage REIT, faced a 17.5% earnings revision downward. These revisions reflect growing bearish sentiment as analysts adjust expectations. The Zacks Rank #5 indicates a strong sell recommendation based on recent downward earnings revisions over 60 days.

Latest articles

Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
Marvell shares active as earnings approach, AI chip focus in view

Marvell shares active as earnings approach, AI chip focus in view

20 May 2026
Marvell Technology shares rose 4.53% to $184.25 in premarket trading Wednesday, extending Tuesday’s 4.35% gain. The company will report fiscal Q1 2027 results after the close on May 27. Analysts at Evercore ISI, Melius Research, and CLSA raised price targets, citing strong demand for custom AI chips. Marvell posted record fiscal 2026 revenue of $8.195 billion in March.
SpaceX restarts Starlink launches after satellite mishap — and another Falcon 9 is already queued

SpaceX IPO Moves Closer as Goldman Nears Top Role in $1.75 Trillion Listing

20 May 2026
Goldman Sachs is set to lead SpaceX’s planned IPO, which could become the largest in history, with a targeted valuation of about $1.75 trillion, Reuters reported. SpaceX aims to publish its prospectus as soon as Wednesday and list on Nasdaq under the ticker SPCX as early as June 12. The company’s next Starship test flight is scheduled for May 21 from Texas. Morgan Stanley, Bank of America, Citigroup, and JPMorgan are also expected to play major roles.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop